Skip to main content
OCSL
NASDAQ Unknown

OCSL Slashes Distribution as NAV Erodes and Credit Losses Deepen

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Credit Services Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$11.93
Mkt Cap
$1.068B
52W Low
$10.63
52W High
$14.31
52W Position info
12% above low
Off High info
17% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

OCSL is trading near its 52-week low of $10.63 (12% above the low).

Summary

OCSL's fiscal Q3 brought a dip in NII per share, a declining NAV, and a 25% distribution cut amid mounting credit losses. A wide discount to NAV further limits capital-raising options.


Key Events · Earnings and Guidance · OCSL

  • Distribution Cut

    The quarterly distribution was reduced by 25% to $0.30 per share from $0.40, alongside a $0.04 supplemental. The board pointed to lower earnings and a goal of aligning payouts with taxable income.

  • NAV Decline

    Net asset value per share fell to $15.70 from $16.64 at September 30, 2025, pressured by net realized and unrealized losses on investments.

  • Credit Deterioration

    Six portfolio companies are on non-accrual status, representing 4.2% of debt investments at cost. Net realized losses for the quarter reached $49.5 million, driven primarily by Dominion Diagnostics, Mosaic Companies, and Spanx.

  • Earnings Pressure

    Net investment income per share came in at $0.37, down from $0.38 a year ago, as lower reference rates weighed on interest income. Total investment income declined 7.8% year-over-year.


Analysis · OCSL · Unknown

A challenging quarter unfolded for Oaktree Specialty Lending. Net investment income per share edged down to $0.37 from $0.38 a year ago, while net asset value dropped to $15.70 from $16.64 at fiscal year-end. Reflecting caution around earnings power, the board cut the quarterly distribution by 25% to $0.30 from $0.40. Credit quality worsened materially: six investments are now on non-accrual, and the company absorbed $49.5 million in net realized losses, largely tied to Dominion Diagnostics, Mosaic, and Spanx. With the stock trading at a steep discount to NAV, equity issuance is constrained, forcing greater reliance on portfolio cash flows to fund the dividend.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OCSL was trading at $11.93 on NASDAQ in the Unknown sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $10.63 to $14.31. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OCSL - Latest Insights

OCSL
Nov 17, 2026, 6:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.09
Real-time Price: $11.83 info
Change: -$0.2637 (-2%) info
Market Cap: $1.037B info
OCSL
Nov 16, 2026, 7:02 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $12.09
Real-time Price: $11.83 info
Change: -$0.2637 (-2%) info
Market Cap: $1.037B info
OCSL
Sep 09, 2026, 6:00 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.66
Real-time Price: $11.83 info
Change: -$0.8337 (-7%) info
Market Cap: $1.037B info
OCSL
Sep 09, 2026, 5:09 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $12.66
Real-time Price: $11.83 info
Change: -$0.8337 (-7%) info
Market Cap: $1.037B info
OCSL
Aug 05, 2026, 6:18 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.93
Real-time Price: $11.83 info
Change: -$0.1037 (-0.87%) info
Market Cap: $1.037B info